Copyright
©The Author(s) 2025.
World J Psychiatry. Aug 19, 2025; 15(8): 104221
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.104221
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.104221
Table 3 Comparison of the Bech-Rafaelsen Mania scale score (mean ± SD)
Baseline | 1 week | 2 weeks | 4 weeks | 8 weeks | 16 weeks | 24 weeks | |
A group | 3.59 ± 2.86 | 1.09 ± 1.69 | 0.28 ± 0.58 | 0.16 ± 0.45 | 0.16 ± 0.57 | 0.16 ± 0.44 | 0.31 ± 0.93 |
B group | 3.15 ± 2.86 | 1.18 ± 1.55 | 0.33 ± 0.85 | 0.15 ± 0.44 | 0.06 ± 0.24 | 0.03 ± 0.17 | 0.15 ± 0.57 |
t value | 0.623 | -0.219 | -0.287 | 0.043 | 0.880 | 1.503 | 0.845 |
P value | 0.536 | 0.827 | 0.775 | 0.966 | 0.382 | 0.138 | 0.401 |
- Citation: Lei LL, Ge CJ, Wang H, Fang Y, Zeng L, Wang SL, Qian MC. Application and efficacy of quetiapine in patients with high-risk factors for bipolar disorder: A randomized controlled trial. World J Psychiatry 2025; 15(8): 104221
- URL: https://www.wjgnet.com/2220-3206/full/v15/i8/104221.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i8.104221